These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7862890)

  • 1. Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study.
    Foulds J; McSorley K; Sneddon J; Feyerabend C; Jarvis MJ; Russell MA
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):163-6. PubMed ID: 7862890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low dose of subcutaneous nicotine improves information processing in non-smokers.
    Le Houezec J; Halliday R; Benowitz NL; Callaway E; Naylor H; Herzig K
    Psychopharmacology (Berl); 1994 May; 114(4):628-34. PubMed ID: 7855225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-smokers show acute tolerance to subcutaneous nicotine.
    Russell MA; Jarvis MJ; Jones G; Feyerabend C
    Psychopharmacology (Berl); 1990; 102(1):56-8. PubMed ID: 2392509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.
    Foulds J; Stapleton J; Swettenham J; Bell N; McSorley K; Russell MA
    Psychopharmacology (Berl); 1996 Sep; 127(1):31-8. PubMed ID: 8880941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
    Myers CS; Taylor RC; Moolchan ET; Heishman SJ
    Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers.
    Foulds J; Stapleton JA; Bell N; Swettenham J; Jarvis MJ; Russell MA
    Drug Alcohol Depend; 1997 Mar; 44(2-3):105-15. PubMed ID: 9088782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.
    Knott V; Engeland C; Mohr E; Mahoney C; Ilivitsky V
    Neuropsychobiology; 2000; 41(4):210-20. PubMed ID: 10828731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M; Babb D; Hatsukami DK
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T
    Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
    Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
    Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical pharmacological study of subcutaneous nicotine.
    Le Houezec J; Jacob P; Benowitz NL
    Eur J Clin Pharmacol; 1993; 44(3):225-30. PubMed ID: 8491235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers.
    Kumari V; Cotter PA; Checkley SA; Gray JA
    Psychopharmacology (Berl); 1997 Aug; 132(4):389-95. PubMed ID: 9298517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking history, instructions and the effects of nicotine: two pilot studies.
    Hughes JR; Strickler G; King D; Higgins ST; Fenwick JW; Gulliver SB; Mireault G
    Pharmacol Biochem Behav; 1989 Sep; 34(1):149-55. PubMed ID: 2696983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials.
    Knott V; Bosman M; Mahoney C; Ilivitsky V; Quirt K
    Pharmacol Biochem Behav; 1999 Jun; 63(2):253-61. PubMed ID: 10371654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of tobacco smoking and nasal nicotine.
    Teter CJ; Asfaw B; Ni L; Lutz M; Domino EF; Guthrie SK
    Eur J Clin Pharmacol; 2002 Aug; 58(5):309-14. PubMed ID: 12185553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of electroencephalographic and cardiovascular changes to plasma nicotine levels in tobacco smokers.
    Kadoya C; Domino EF; Matsuoka S
    Clin Pharmacol Ther; 1994 Apr; 55(4):370-7. PubMed ID: 8162662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-administration of intravenous nicotine in male and female cigarette smokers.
    Sofuoglu M; Yoo S; Hill KP; Mooney M
    Neuropsychopharmacology; 2008 Mar; 33(4):715-20. PubMed ID: 17534380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.